Mucopolysaccharidosis Type IIIB
6 clinical trials · Condition
◉ Watch Mucopolysaccharidosis Type IIIB
| Record | Firm | Date |
|---|---|---|
| A Treatment Extension Study of Mucopolysaccharidosis Type IIIB (NCT03784287) | Allievex Corporation | 2018-02-19 |
| A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB) (NCT03227042) | Allievex Corporation | 2017-11-16 |
| A Treatment Study of Mucopolysaccharidosis Type IIIB (NCT02754076) | Allievex Corporation | 2016-04-01 |
| A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB) (NCT02493998) | Allievex Corporation | 2015-11-01 |
| Natural History Studies of Mucopolysaccharidosis III (NCT02037880) | Nationwide Children's Hospital | 2014-02-01 |
| Early Access Treatment With Tralesinidase Alfa in Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome Type B) (NCT07733856) | Spruce Biosciences |
Track Mucopolysaccharidosis Type IIIB automatically
Every clearance here is in the API, with alerts when new ones post.